IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301) (PRISM-MEL-301)

February 23, 2026 updated by: Immunocore Ltd

A Phase 3 Randomized, Controlled Study of IMC-F106C Plus Nivolumab Versus Nivolumab Regimens in HLA-A*02:01-Positive Participants With Previously Untreated Advanced Melanoma (PRISM-MEL-301

This is a phase 3, randomized, controlled study of brenetafusp (IMC-F106C) plus nivolumab compared to standard nivolumab regimens in HLA-A*02:01-positive participants with previously untreated advanced melanoma.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

680

Phase

  • Phase 3

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Buenos Aires, Argentina, C1199ABD
        • Recruiting
        • Hospital Italiano de Buenos Aires (HIBA)
      • CABA, Argentina, CP1426ANZ
        • Recruiting
        • Instituto Alexander Fleming
      • Córdoba, Argentina, X5008HHW
        • Recruiting
        • CEMAIC (Centro Privado de Especialidades Medicas Ambulatorias e Investigacion Clinica
        • Contact:
      • Viedma, Argentina, R8500ACE
        • Recruiting
        • Clinica Viedma
        • Contact:
    • Buenos Aires
      • Caba, Buenos Aires, Argentina, 1213
      • Caba, Buenos Aires, Argentina, C1430EGF
        • Recruiting
        • Clínica Adventista Belgrano - Sector Investigación
        • Contact:
      • Heidelberg, Australia, 3084
        • Recruiting
        • Austin Hospital
      • North Melbourne, Australia, 3051
      • Wollstonecraft, Australia
        • Recruiting
        • University of Sydney - Melanoma Institute Australia (MIA) - The Poche Centre
      • Woolloongabba, Australia
        • Recruiting
        • The University of Queensland (UQ) - Princess Alexandra Hospital (PAH)
    • New South Wales
      • Waratah, New South Wales, Australia, 02298
    • Queensland
      • Greenslopes, Queensland, Australia, 4120
        • Completed
        • Gallipoli Medical Research Foundation (Greenslopes Private Hospital)
    • Western Australia
      • Nedlands, Western Australia, Australia, 06009
      • Nedlands, Western Australia, Australia, 06009
      • Graz, Austria, 8036
      • Pölten, Austria
        • Recruiting
        • Universitätsklinikum St. Pölten
      • Salzburg, Austria, 5020
        • Recruiting
        • Paracelsus Medizinischen Privatuniversitaet - SALK - Universitaetsklinik fuer Dermatologie - EB-Haus Austria
      • Vienna, Austria, 1090
        • Recruiting
        • AKH - Medizinische Universitat Wien
        • Contact:
          • Prof. Höller Christoph
          • Phone Number: 43 (0)1 40400 77310
      • Anderlecht, Belgium, 01070
        • Recruiting
        • Universite Libre de Bruxelles (ULB)-Institut Jules Bordet
        • Contact:
      • Bruges, Belgium, 8000
        • Recruiting
        • AZ Sint-Jan Brugge-Oostende AV-Campus Sint-Jan
        • Contact:
      • Brussels, Belgium, 1090
      • Brussels, Belgium, 1200
      • Leuven, Belgium, 03000
      • Barretos, Brazil, 14784
        • Recruiting
        • Fundação Pio XII - Hospital de Câncer de Barretos - Hospital de Amor
      • Brasília, Brazil, DF CEP 70200-730
        • Recruiting
        • Hospital Sirio-Libanes (HSL) - Centro de Oncologia - Brasilia
        • Contact:
      • Florianópolis, Brazil, 88034-000
        • Recruiting
        • Centro de Pesquisas Oncologicas (CEPON)
        • Contact:
      • Fortaleza, Brazil, 60135-237
        • Recruiting
        • Oncocentro Sao Carlos Hospital
        • Contact:
      • Liberdade, Brazil, 01509-010
        • Recruiting
        • A.C.Camargo Cancer Center - Centro Internacional de Pesquisa (CIPE)
        • Contact:
      • Porto Alegre, Brazil, 90035-903
        • Recruiting
        • Hospital de Clinicas de Porto Alegre (HCPA)
        • Contact:
        • Contact:
      • Porto Alegre, Brazil, 90610-000
        • Recruiting
        • Pontificia Universidade Catolica do Rio Grande do Sul (PUCRS) - Hospital Sao Lucas - Centro de Pesquisa Clinica (CPC)
        • Contact:
      • Rio de Janeiro, Brazil, 20220-410
        • Recruiting
        • National Cancer Institute
        • Contact:
      • Rio de Janeiro, Brazil, 22775-001
        • Recruiting
        • Instituto Américas - Instituto de Educação Pesquisa e Gestão em Saúde Oncosite
        • Contact:
      • São Paulo, Brazil, 01246-000
        • Recruiting
        • Instituto do Cancer do Estado de Sao Paulo (ICESP)
      • São Paulo, Brazil, 01308-070
      • São Paulo, Brazil, 15090-000
        • Recruiting
        • Faculdade de Medicina de Sao Jose do Rio Preto-SP (FAMERP) - Hospital de Base (HB) - Centro Integrado de Pesquisa (CIP)
        • Contact:
    • Rio Grande do Sul
      • Ijuí, Rio Grande do Sul, Brazil, 98700-000
        • Recruiting
        • Centro de Pesquisa Clinica em Oncologia - Oncosite
        • Contact:
      • Porto Alegre, Rio Grande do Sul, Brazil, 90110-270
        • Recruiting
        • Centro Gaucho Integrado de Oncologia, Hematologia, Ensino e Pesquisa LTDA
        • Contact:
      • Panagyurishte, Bulgaria, 4500
        • Recruiting
        • Uni Hospital
        • Contact:
      • Plovdiv, Bulgaria, 4000
        • Recruiting
        • Complex Oncology Center - Plovdiv Ltd.
      • Sofia, Bulgaria
        • Recruiting
        • Regina Life Clinic
      • Sofia, Bulgaria, 1527
        • Recruiting
        • University Hospital Tsaritsa Yoanna (ISUL) (Queen Giovanna University Hospital)
      • Edmonton, Canada, T6G 1Z2
        • Recruiting
        • Cross Cancer Institute
        • Contact:
          • Dr. John Walker, MD
          • Phone Number: 780-577-8082
    • Ontario
      • Toronto, Ontario, Canada, M5G 2C1
        • Recruiting
        • Princess Margaret Cancer Centre
        • Contact:
      • Hradec Králové, Czechia, 500 05
        • Recruiting
        • Fakultni Nemocnice Hradec Kralove (FNHK) - Klinika Onkologie a Radioterapie
        • Contact:
      • Olomouc, Czechia, 77900
        • Recruiting
        • Fakultni Nemocnice Olomouc (FNOL)
        • Contact:
      • Prague, Czechia, 110 00
        • Completed
        • Sanatorium Profesora Arenbergera
      • Herlev, Denmark, 2730
        • Recruiting
        • Kobenhavns Universitet - Herlev Hospital (Amtssygehuset i Herlev)
        • Contact:
      • Helsinki, Finland, 00290
        • Recruiting
        • Helsingin Yliopistollinen Keskussairaala - Cancercentrum
        • Contact:
      • Tampere, Finland, 33520
        • Recruiting
        • Pirkanmaan Sairaanhoitopiiri (Pirkanmaa Hospital District)-Tampereen Yliopistollinen Sairaala (Tampere University Hospital)
        • Contact:
      • Turku, Finland, 20520
        • Recruiting
        • Turun Yliopistollinen Keskussairaala (TYKS)
        • Contact:
      • Bobigny, France, 93000
        • Completed
        • Assistance Publique-Hopitaux de Paris (AP-HP) - Hopitaux Universitaires Paris Seine-Saint-Denis - Hopital Avicenne
      • Boulogne-Billancourt, France, 92104
        • Recruiting
        • Assistance Publique-Hopitaux de Paris (AP-HP) - Hopital Ambroise-Pare
      • Caen, France, 14000
      • Dijon, France
      • Lille, France, 59037
        • Recruiting
        • Centre Hospitalier Universitaire de Lille (CHU Lille)-Hopital Claude Huriez
        • Contact:
      • Nantes, France
        • Recruiting
        • Centre Hospitalier Universitaire de Nantes (CHU de Nantes) - Hotel-Dieu
      • Paris, France, 75010
        • Recruiting
        • Hospital Saint Louis
      • Pierre-Bénite, France, 69310
        • Recruiting
        • Hospices Civils de Lyon (HCL) - Centre Hospitalier Lyon-Sud
      • Rouen, France, 76031
      • Valence, France, 26000
        • Recruiting
        • Hopital Robert Debre
      • Villejuif, France, 94800
        • Recruiting
        • Institut Gustave Roussy (IGR) Service de Dermatolgie
    • Cedex
      • Marseille, Cedex, France, 13385
        • Recruiting
        • Hopital de la Timone
      • Toulouse, Cedex, France, 31059
        • Recruiting
        • Oncopole Claudius Regaud- Institut Universitaire du Cancer de Toulouse
      • Berlin, Germany, 10115
        • Recruiting
        • Charite-Universitaetsmedizin Berlin - Campus Charite Mitte (CCM) - Klinik fuer Dermatologie Venerologie und Allergologie - Hauttumorcentrum Charite (HTCC)
        • Contact:
        • Contact:
      • Bremen, Germany, 28205
      • Dortmund, Germany, 44137
        • Recruiting
        • Klinikum Dortmund gGmbH - Klinikzentrum Mitte - Hautklinik
      • Dresden, Germany, 01307
        • Recruiting
        • Universitätsklinikum Carl Gustav Carus
        • Contact:
          • Daniela Walther
          • Phone Number: 0049 351 458 19782
      • Erfurt, Germany, 99089
        • Recruiting
        • Helios Klinikum Erfurt - Klinik fuer Hautkrankheiten und Allergologie
        • Contact:
      • Erlangen, Germany, 91054
      • Essen, Germany, 45122
      • Frankfurt, Germany, 60590
        • Recruiting
        • Johann Wolfgang Goethe-Universitaet Frankfurt am Main - Klinik fuer Dermatologie, Venerologie und Allergologie
        • Contact:
      • Giessen, Germany, D-35392
        • Recruiting
        • Justus-Liebig-Universitaet Giessen - Klinik fuer Dermatologie und Andrologie
        • Contact:
          • Phone Number: (+)49641-985-43200
      • Hamburg, Germany, 20246
        • Recruiting
        • University of Hamburg
        • Contact:
      • Hamburg, Germany, 22045
        • Recruiting
        • Elbe Kliniken Stade - Hautkrebszentrum Buxtehude
        • Contact:
      • Heidelberg, Germany, 69120
      • Kiel, Germany, DE-24105
        • Recruiting
        • University Hospital Schleswig-Holstein
      • Leipzig, Germany, 4103
        • Recruiting
        • Universitaetsklinikum Leipzig - Klinik fuer Dermatologie, Venerologie und Allergologie
        • Contact:
      • Mainz, Germany, D-55131
      • Marburg, Germany, 35043
        • Recruiting
        • Universitaetsklinikum Giessen und Marburg GmbH - Marburg
      • Minden, Germany, 32429
      • Munich, Germany, 81377
        • Recruiting
        • LMU Klinikum - Klinik und Poliklinik fur Dermatologie und Allergologie
        • Contact:
      • Tübingen, Germany, 72076
        • Recruiting
        • Universitaetsklinikum Tuebingen (UKT) - Zentrum fuer Dermatoonkologie - Hautklinik
        • Contact:
      • Würzburg, Germany, 97080
        • Recruiting
        • Universitaetsklinikum Wuerzburg - Klinik und Poliklinik fuer Dermatologie Venerologie und Allergologie
        • Contact:
      • Budapest, Hungary, 1085
      • Budapest, Hungary, 1122
        • Recruiting
        • Orszagos Onkologiai Intezet (National Institute of Oncology)
        • Contact:
      • Debrecen, Hungary
        • Recruiting
        • Debreceni Egyetem-Klinikai Kozpont (DEKK)
        • Contact:
      • Pécs, Hungary, 7624
        • Recruiting
        • Pecsi Tudomanyegyetem (PTE) (University of Pecs)
        • Contact:
      • Szeged, Hungary, 6720
        • Recruiting
        • Szegedi Tudomanyegyetem (University of Szeged)
        • Contact:
      • Bari, Italy, 70124
        • Recruiting
        • Istituto Tumori Giovanni Paolo II - Ospedale Oncologico di Bari
      • Bergamo, Italy, 24125
        • Recruiting
        • Humanitas Gavazzeni (Cliniche Gavazzeni S.p.A)
      • Meldola, Italy, 47014
        • Recruiting
        • IRCCS Istituto Scientifico Romagnolo per lo Studio dei Tumori "Dino Amadori" Srl (IRST)
      • Milan, Italy, 20141
        • Recruiting
        • Istituto Europeo di Oncologia (IEO) (European Institute of Oncology)
        • Contact:
      • Milan, Italy, 20133
        • Recruiting
        • Fondazione IRCCS - Istituto Nazionale dei Tumori - Milano
      • Modena, Italy, 41124
        • Recruiting
        • Azienda Ospedaliero-Universitaria di Modena (AOU Modena) - Policlinico di Modena - Day Hospital Oncologico
      • Napoli, Italy, 80131
        • Recruiting
        • Istituto Nazionale Tumori (INT) "Fondazione G. Pascale" di Napoli
      • Padua, Italy, 35128
        • Recruiting
        • Istituto Oncologico Veneto (IOV) IRCCS
      • Padua, Italy, I-35128
        • Recruiting
        • Istituto Oncologico Veneto (IOV) IRCCS
      • Perugia, Italy, 06129
        • Recruiting
        • Azienda Ospedaliera di Perugia - Ospedale Santa Maria della Misericordia
      • Ponderano, Italy, 13875
        • Recruiting
        • Azienda Sanitaria Locale di Biella (ASL BI) - Ospedale degli Infermi
      • Roma, Italy, 0168
        • Recruiting
        • Fondazione Policlinico Universitario Agostino Gemelli IRCCS
      • Roma, Italy, 00128
        • Recruiting
        • National Cancer Institute Regina Elena
      • Siena, Italy, 53100
        • Recruiting
        • " Azienda Ospedaliera Universitaria Senese - Policlinico Santa Maria Alle Scotte - Clinica Immunoterapia Oncologica"
      • Torino, Italy, 10126
        • Recruiting
        • Azienda Ospedaliera Universitaria Citta Della Salute E Della Scienza Di Torino
      • Kaunas, Lithuania, 50161
        • Recruiting
        • Hospital of Lithuanian University of Health Sciences Kauno Klinikos
        • Contact:
      • Vilnius, Lithuania, LT-08406
        • Recruiting
        • Vilnius University Hospital Santaros Clinics Affiliate National Cancer Center
        • Contact:
      • Mexico City, Mexico, 04701
        • Recruiting
        • Centro Oncologico Internacional(COI) - Ciudad de Mexico
    • Jalisco
      • Guadalajara, Jalisco, Mexico, 44280
        • Recruiting
        • Antiguo Hospital Civil de Guadalajara "Fray Antonio Alcalde"
      • Bergen, Norway, 05009
      • Oslo, Norway, 0379
        • Recruiting
        • Oslo University Hospital
        • Contact:
      • Bydgoszcz, Poland, 85796
        • Completed
        • Centrum Onkologii im. Prof. Franciszka Łukaszczyka
      • Gdansk, Poland, 80-214
        • Recruiting
        • Klinika Onkologii i Radioterapii Uniwersyteckie Centrum Kliniczne
        • Contact:
      • Skorzewo, Poland, 60185
        • Completed
        • Centrum Medyczne Pratia Poznan - Skorzewo
      • Warsaw, Poland, 02-781
        • Recruiting
        • Klinika Nowotworów Tkanek Miękkich, Kości i Czerniaków
        • Contact:
      • Coimbra, Portugal, 3004-561
        • Recruiting
        • Centro Hospitalar e Universitario de Coimbra EPE (CHUC)
      • Lisbon, Portugal, 1099-023
        • Recruiting
        • Instituto Portugues de Oncologio de Lisboa Francisco Gentil EPE (IPO Lisboa) (IPOLFG)
        • Contact:
      • Lisbon, Portugal, 1649-035
      • Cluj-Napoca, Romania, 400015
        • Recruiting
        • L'Institute Oncologique Prof. Dr. Ion Chiricuta (IOCN) (The Oncology Institute Prof. Dr. Ion. Chiricuta)
        • Contact:
      • Craiova, Romania, 200542
        • Recruiting
        • Sf Nectarie Oncology Center
        • Contact:
      • Iași, Romania, 700106
        • Recruiting
        • Victoria Hospital (Centrul de oncologie Euroclinic SRL) (Centrul De Oncologie Medicala) (Euroclinic Onchology Center)
        • Contact:
      • A Coruña, Spain, 15006
        • Recruiting
        • Complejo Hospitalario Universitario A Coruña (CHUAC)
      • Barcelona, Spain, 08035
        • Recruiting
        • Hospital Universitari Vall D'Hebron
      • Barcelona, Spain, 8036
      • Barcelona, Spain, 08908
        • Recruiting
        • Hospital Duran i Reynals
      • Barcelona, Spain, 08035
        • Recruiting
        • Hospital Universitario Dexeus
      • Córdoba, Spain, 14004
      • Granada, Spain, 18014
        • Recruiting
        • Hospital Universitario Virgen de las Nieves (HUVN)
        • Contact:
      • Las Palmas de Gran Canaria, Spain, 35016
      • Madrid, Spain, 28034
        • Recruiting
        • Hospital Universitario Ramon Y Cajal
      • Madrid, Spain, 28046
        • Recruiting
        • Hospital Universitario La Paz
        • Contact:
      • Madrid, Spain, 28009
        • Recruiting
        • Hospital General Universitario Gregorio Marañon
        • Contact:
      • Madrid, Spain, 28050
        • Recruiting
        • Centro Integral Oncológico Clara Campal (CIOCC)
      • Madrid, Spain, 28027
        • Recruiting
        • Universidad de Navarra - Clinica Universidad de Navarra (CUN) - Madrid
        • Contact:
      • Madrid, Spain, 28041
        • Recruiting
        • Universidad Complutense de Madrid (UCM)-Hospital Universitario 12 de Octubre (H12O)
        • Contact:
      • Málaga, Spain, 29016
        • Recruiting
        • Hospital Regional Universitario de Malaga
        • Contact:
      • Pamplona, Spain, 31008
        • Recruiting
        • Universidad de Navarra - Clinica Universidad de Navarra (CUN) - Pamplona
        • Contact:
      • Reus, Spain, 43204
      • San Sebastián, Spain, 20014
        • Recruiting
        • Onkologikoa - Kutxaren Institutu Onkologikoa (Instituto Oncologico De Guipuzcoa)
        • Contact:
          • Ainhoa Arocena
          • Phone Number: 94 332 8315
        • Contact:
          • Lidia Nieto
          • Phone Number: 94 332 8315
      • Seville, Spain, 41013
        • Recruiting
        • Hospital Universitario Virgen Del Rocio
      • Seville, Spain, 41009
        • Recruiting
        • Hospital Universitario Virgen Macarena
        • Contact:
      • Valencia, Spain, 46026
        • Recruiting
        • Universitat de Valencia - Hospital Universitari i Politecnic La Fe de Valencia (Hospital La Fe Bulevar Sur)
        • Contact:
        • Contact:
          • Phone Number: 34 96 124 41 88
      • Valencia, Spain, 46014
        • Recruiting
        • Hospital Clinico Universitario de Valencia
      • Valencia, Spain, 46010
        • Recruiting
        • Instituto de Investigacion Sanitaria (INCLIVA) (Institute of Health Research Hospital Clinic of Valencia)
        • Contact:
      • Zaragoza, Spain, 50009
        • Recruiting
        • Servicio Aragones de Salud - Hospital Universitario Miguel Servet (HUMS)
    • Cantabria
      • Santander, Cantabria, Spain, 39008
        • Recruiting
        • Universidad de Cantabria (UC) - Hospital Universitario Marques de Valdecilla (HUMV)
        • Contact:
    • Murcia
      • El Palmar, Murcia, Spain, 30120
        • Recruiting
        • Universidad de Murcia - Hospital Universitario Virgen de la Arrixaca (HUVA)
        • Contact:
      • Gothenburg, Sweden, SE41345
        • Recruiting
        • Sahlgrenska Akademin - Institutionen for Kliniska Vetenskaper (Institute of Clinical Sciences)
      • Jönköping, Sweden, 553 05
        • Recruiting
        • Lanssjukhuset Ryhov - Onkologiska Kliniken
        • Contact:
      • Lund, Sweden, 22185
        • Recruiting
        • Skanes Universitetssjukhus - Lund - Onkologiska Klinik
      • Stockholm, Sweden, 171 76
      • Uppsala, Sweden, SE75185
        • Recruiting
        • Uppsala Universitet - Akademiska Sjukhuset (Uppsala University Hospital)
      • Zurich, Switzerland, 8901
        • Recruiting
        • UniversitaetsSpital Zuerich - Dermatologische Klinik
        • Contact:
      • Altındağ, Turkey (Türkiye), 6230
        • Recruiting
        • Kanser Enstitusu (Hacettepe University Cancer Institute)
      • Ankara, Turkey (Türkiye), 6100
        • Recruiting
        • T.C. Saglik Bakanligi - SBU Gulhane Egitim ve Arastirma Hastanesi
        • Contact:
      • Malatya, Turkey (Türkiye), 44280
        • Recruiting
        • Inonu Universitesi - Turgut Ozal Tip Merkezi
        • Contact:
      • Samsun, Turkey (Türkiye), 55270
        • Recruiting
        • Ondokuz Mayis Universitesi (OMU) - Tip Facultesi
        • Contact:
      • Seyhan, Turkey (Türkiye), 1140
        • Recruiting
        • Medical Park Seyhan Hastanesi
        • Contact:
      • Yenimahalle, Turkey (Türkiye), 06170
        • Recruiting
        • T.C. Saglik Bakanligi - Ankara Etlik sehir Hastanesi
        • Contact:
      • Çankaya, Turkey (Türkiye), 6800
        • Recruiting
        • Ankara Bilkent City Hospital, Oncology Department
    • Adana
      • Yüreğir, Adana, Turkey (Türkiye), 1370
        • Recruiting
        • T.C. Saglik Bakanligi - Adana Numune Egitim ve Arastirma Hastanesi (Adana Numune Education and Research Hospital)
        • Contact:
    • Ankara
      • Çankaya, Ankara, Turkey (Türkiye), 06520
        • Recruiting
        • Memorial Saglik Grubu - Memorial Ankara Hastanesi
        • Contact:
    • Antalya
      • Kepez, Antalya, Turkey (Türkiye), 7025
        • Recruiting
        • Memorial Antalya Hastanesi
        • Contact:
    • Campus
      • Antalya, Campus, Turkey (Türkiye), 07070
        • Recruiting
        • Medical Park Hastaneler Grubu - I.A.U. VM Medical Park Florya
        • Contact:
    • Gaziantep
      • Şehitkamil, Gaziantep, Turkey (Türkiye), 27584
        • Recruiting
        • Medical Park Gaziantep Hastanesi
        • Contact:
    • Istanbul
      • Bahçelievler, Istanbul, Turkey (Türkiye), 34180
        • Recruiting
        • Memorial Saglik Grubu - Memorial Bahcelievler Hastanesi
        • Contact:
          • Hakan Harputluoglu
    • İzmir
      • Bornova, İzmir, Turkey (Türkiye), 35100
        • Recruiting
        • Ege Universitesi Tip Fakultesi (Ege University Faculty of Medicine)
        • Contact:
      • Cordaleo, İzmir, Turkey (Türkiye), 35575
        • Recruiting
        • Izmir Ekonomi Universitesi Medikal Point Hastanesi
        • Contact:
      • Birmingham, United Kingdom, B15 2TH
        • Recruiting
        • Queen Elizabeth Hospital Birmingham
      • Cambridge, United Kingdom, CB20QQ
        • Recruiting
        • Cambridge University Hospitals NHS Foundation Trust - Addenbrooke's Hospital (AH) - Oncology Centre
      • Glasgow, United Kingdom, G12 0YN
        • Recruiting
        • Beatson West of Scotland Cancer Centre
        • Contact:
      • Liverpool, United Kingdom, L78YA
        • Recruiting
        • The Clatterbridge Cancer Centre NHS Foundation Trust
        • Contact:
      • London, United Kingdom, W1G 6AD
        • Completed
        • Sarah Cannon Research Institute (SCRI) - London (SCRI-UK)
      • Manchester, United Kingdom, M204BX
        • Recruiting
        • The Christie NHS Foundation Trust
      • Oxford, United Kingdom, Ox37LE
        • Recruiting
        • University of Oxford
        • Contact:
          • Dr Miranda Payne, MD
          • Phone Number: 01 865 74 1841
      • Surrey Quays, United Kingdom, SM2 5PT
        • Recruiting
        • Royal Marsden Hospital - Sutton
    • Arizona
      • Tucson, Arizona, United States, 85720
        • Recruiting
        • University of Arizona
        • Contact:
    • California
      • La Jolla, California, United States, 92093-0698
        • Recruiting
        • University of California - San Diego
        • Contact:
      • Los Angeles, California, United States, 90095
        • Recruiting
        • UCLA Hematology/Oncology
        • Contact:
      • Los Angeles, California, United States, 90025
        • Recruiting
        • The Angeles Clinic and Research Institute- West Los Angeles
        • Contact:
      • Los Angeles, California, United States, 90033
        • Recruiting
        • ESC Norris Comprehensive Cancer Center
        • Contact:
      • Palo Alto, California, United States, 94304
        • Completed
        • Stanford Cancer Institute - Stanford Cancer Center Palo Alto
      • Santa Monica, California, United States, 90404
        • Recruiting
        • Saint John's Health Center - John Wayne Cancer Institute (JWCI)
        • Contact:
    • Colorado
      • Aurora, Colorado, United States, 80045
        • Recruiting
        • University of Colorado, Anschutz Medical Campus
        • Contact:
      • Denver, Colorado, United States, 80222
    • Connecticut
      • Farmington, Connecticut, United States, 06030-2205
        • Completed
        • UConn Health-Farmington (University of Connecticut Health Center (UCHC))
    • District of Columbia
      • Washington D.C., District of Columbia, United States, 20007
        • Recruiting
        • Georgetown University
    • Florida
      • Jacksonville, Florida, United States, 32224
        • Recruiting
        • Mayo Clinic Florida
        • Contact:
      • Miami, Florida, United States, 33136
        • Recruiting
        • University of Miami Health System-Sylvester Comprehensive Cancer Center-Miami
        • Contact:
    • Illinois
      • Chicago, Illinois, United States, 60611
        • Recruiting
        • Northwestern University - Robert H. Lurie Comprehensive Cancer Center - NMDTI
    • Kansas
      • Westwood, Kansas, United States, 66205
        • Recruiting
        • The University of Kansas Cancer Center (KUCC) - Westwood
        • Contact:
    • Kentucky
      • Edgewood, Kentucky, United States, 41017
    • Massachusetts
      • Boston, Massachusetts, United States, 02114
        • Recruiting
        • Massachusetts General Hospital
        • Contact:
      • Boston, Massachusetts, United States, 02215
    • Michigan
      • Detroit, Michigan, United States, 04820
        • Recruiting
        • Henry Ford Cancer Center - Michigan
        • Contact:
    • Minnesota
      • Minneapolis, Minnesota, United States, 55407
        • Recruiting
        • Allina Health Cancer Institute - Minneapolis
        • Contact:
    • Missouri
      • St Louis, Missouri, United States, 63110
        • Completed
        • Washington University School of Medicine
    • New Jersey
      • Hackensack, New Jersey, United States, 07601
        • Recruiting
        • John Theurer Cancer Center at Hackensack University Medical Center
        • Contact:
    • New York
      • Lake Success, New York, United States, 11042
        • Recruiting
        • Northwell Health Cancer Institute
        • Contact:
      • New York, New York, United States, 10032
        • Completed
        • Columbia University Medical Center
    • Ohio
      • Columbus, Ohio, United States, 43210
    • Pennsylvania
      • Philadelphia, Pennsylvania, United States, 19107
      • Pittsburgh, Pennsylvania, United States, 15232
        • Recruiting
        • UPMC Hillman Cancer Center
        • Contact:
    • South Carolina
      • Greenville, South Carolina, United States, 29605
      • Spartanburg, South Carolina, United States, 29303
        • Recruiting
        • Spartanburg Regional Healthcare System - Spartanburg Medical Center (SMC)
        • Contact:
    • Tennessee
      • Knoxville, Tennessee, United States, 37920
        • Recruiting
        • The University of Tennessee - Knoxville (UTK)
        • Contact:
          • Megan McKenzie, RN
          • Phone Number: 865-305-6284
      • Nashville, Tennessee, United States, 37203
        • Recruiting
        • Tennessee Oncology, PLLC
        • Contact:
      • Nashville, Tennessee, United States, 37203
        • Recruiting
        • Sarah Cannon Research Institute: USA/TN
    • Texas
      • Dallas, Texas, United States, 75235-9179
    • Utah
      • Salt Lake City, Utah, United States, 84112
        • Recruiting
        • University of Utah Huntsman Cancer Institute
        • Contact:
    • Virginia
      • Charlottesville, Virginia, United States, 22903
      • Richmond, Virginia, United States, 23298-0070
        • Recruiting
        • Virginia Commonwealth University (VCU) - Massey Cancer Center
        • Contact:
    • Washington
      • Seattle, Washington, United States, 98104
        • Recruiting
        • Swedish Medical Center - Swedish Cancer Institute (SCI) - First Hill Campus
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Participants must be HLA-A*02:01-positive
  • Participants must have histologically confirmed Stage IV or unresectable Stage III melanoma
  • Archived or fresh tumor tissue sample that must be confirmed as adequate
  • Participants must have measurable disease per RECIST 1.1
  • Participant must have BRAF V600 mutation status determined
  • Participants must have an Eastern Cooperative Oncology Group (ECOG) performance status score of 0 or 1
  • Male and female participants of childbearing potential who are sexually active with a non-sterilized partner must agree to use highly effective methods of birth control from the study screening date until 5 months after the final dose of study intervention

Exclusion Criteria:

  • Participants with a history of a malignant disease other than those being treated in this study
  • Participants with untreated, active, or symptomatic central nervous system (CNS) metastases or carcinomatous meningitis
  • Hypersensitivity to IMC-F106C, nivolumab, relatlimab, or any associated excipients
  • Participants with clinically significant pulmonary disease or impaired lung function
  • Participants with clinically significant cardiac disease or impaired cardiac function
  • Participants with active autoimmune disease requiring immunosuppressive treatment
  • Participants with any medical condition that is poorly controlled or that would, in the Investigator's or Sponsor's judgment, adversely impact the participant's participation in the clinical study due to safety concerns, compliance with clinical study procedures, or interpretation of study results
  • Participants who received prior systemic anticancer therapy for unresectable or metastatic melanoma
  • Participants with a history of a life-threatening AE related to prior anti-PD-(L)1 or anti-LAG-3

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Arm C: Nivolumab OR Nivolumab + Relatlimab
Participants receive nivolumab 480 mg monotherapy, or nivolumab 480 mg + relatlimab 160 mg, Q4W.
Concentrate for solution for infusion at a unit dose of 10 mg/mL.
Other Names:
  • OPDIVO
Concentrate for solution for infusion at a unit dose of 16 mg/mL.
Other Names:
  • OPDUALAG
Experimental: Arm A: Brenetafusp Low Dose + Nivolumab

Participants receive brenetafusp Low Dose once weekly (QW) for the first 13 weeks, then every 2 weeks (Q2W) through Week 51, and then every 4 weeks (Q4W). Nivolumab is given Q4W.

Closed to randomization after dose recommendation by the IDMC in November 2025.

Soluble PRAME-specific T cell receptor with anti-CD3 scFV concentrate for solution for intravenous (IV) infusion at a unit dose of 0.2 mg/mL.
Other Names:
  • IMC-F106C
Concentrate for solution for infusion at a unit dose of 10 mg/mL.
Other Names:
  • OPDIVO
Experimental: Arm B: Brenetafusp High Dose + Nivolumab

Participants receive brenetafusp High Dose once weekly (QW) for the first 13 weeks, then every 2 weeks (Q2W) through Week 51, and then every 4 weeks (Q4W). Nivolumab is given Q4W.

Selected as go-forward experimental arm after dose recommendation by the IDMC in November 2025

Soluble PRAME-specific T cell receptor with anti-CD3 scFV concentrate for solution for intravenous (IV) infusion at a unit dose of 0.2 mg/mL.
Other Names:
  • IMC-F106C
Concentrate for solution for infusion at a unit dose of 10 mg/mL.
Other Names:
  • OPDIVO

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Progression-Free Survival (PFS)
Time Frame: Up to ~45 months
PFS as assessed by blinded independent central review (BICR) according to Response Evaluation Criteria in Solid Tumours (RECIST 1.1).
Up to ~45 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Maximum Plasma Concentration (Cmax) of IMC-F106C
Time Frame: Day 1 of Weeks 1, 2, and 3: Predose and 0.5 and 4 hours postdose
The Cmax of IMC-F106C will be reported.
Day 1 of Weeks 1, 2, and 3: Predose and 0.5 and 4 hours postdose
Overall Survival (OS)
Time Frame: Up to ~57 months
OS is the time from randomization to time of death from any cause.
Up to ~57 months
Overall Response Rate (ORR)
Time Frame: Up to ~45 months
ORR as assessed by BICR according to RECIST 1.1.
Up to ~45 months
Number of Participants Experiencing ≥1 Adverse Event (AE)
Time Frame: Up to ~57 months
An AE is defined as the appearance of (or worsening of any pre-existing) undesirable sign, symptom, or medical condition that occur in the study.
Up to ~57 months
Number of Participants Experiencing ≥1 Serious Adverse Event (SAE)
Time Frame: Up to ~57 months
An SAE is any untoward medical consequence that results in death; requires inpatient hospitalization or prolongs existing hospitalization; results in persistent or significant disability/incapacity; is a congenital anomaly/birth defect; or any other important medical event in the opinion of the Investigator.
Up to ~57 months
Number of Participants Experiencing a Dose Interruption, Reduction, or Discontinuation
Time Frame: Up to ~45 months
The number of participants with a dose interruption, reduction, or discontinuation due to AE will be reported.
Up to ~45 months
Incidence of anti-IMC-F106C Antibodies
Time Frame: Up to ~45 months
The incidence of anti-IMC-F106C antibodies, including neutralizing antibodies, will be reported.
Up to ~45 months
Association between PFS and Intra-Tumor Immune Cells
Time Frame: Up to ~45 months
The potential association between the effect of IMC-F106C on efficacy and intra-tumor environment will be explored. Intra-tumor environment is estimated as the ratio of CD3+ to CD163+ cells and the correlation with PFS will be estimated by the hazard ratio (+/- 95% CI) from a Cox model. This analysis will be restricted to subjects randomized to receive IMC-F106C.
Up to ~45 months
Health-Related Quality of Life
Time Frame: Up to ~45 months
The change from baseline over time and between treatments of health-related quality of life will be reported.
Up to ~45 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 5, 2024

Primary Completion (Estimated)

October 16, 2027

Study Completion (Estimated)

October 16, 2027

Study Registration Dates

First Submitted

October 19, 2023

First Submitted That Met QC Criteria

October 31, 2023

First Posted (Actual)

November 1, 2023

Study Record Updates

Last Update Posted (Actual)

February 25, 2026

Last Update Submitted That Met QC Criteria

February 23, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

Yes

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe